Press Releases

Nov 12, 2026
Twist Bioscience Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results
Nov 11, 2026
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Nov 09, 2026
Twist Bioscience to Present at Upcoming Investor Conferences
Nov 03, 2026
Notice of Proposed Derivative Settlement: Twist Bioscience Corporation
Oct 29, 2026
Twist Bioscience Launches MRD Express with Rapid Turnaround Time
Oct 28, 2026
Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies
Oct 26, 2026
Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026
Sep 16, 2026
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
Sep 09, 2026
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference
Aug 04, 2026
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock